The Trump administration has raised alarms about the use of federal dollars for fentanyl test strips, suggesting that such practices may encourage illegal drug use.
Officials argue that this stance represents a significant departure from harm reduction approaches that have been advocated in recent years.
This warning reflects ongoing debates about the best strategies to address the opioid crisis and the role of harm reduction in public health policy.